The children's supplement market is substantial and growing, driven by parental interest in nutritional gaps, immune support, and developmental health. The compliance challenges are real: incorrect Daily Values for pediatric populations, development-related claims that cross into disease territory, and ADHD/behavioral claims that are frequently cited in FDA enforcement.
Age-Specific Daily Values
One of the most common technical violations in children's supplement labeling is using adult Daily Values for products intended for children under 4. FDA has established separate Reference Daily Intakes (RDIs) for:
Infants: birth to 12 months
Children 1-3 years
Children 4-8 years (these align with the adult DVs for most nutrients)
Under 21 CFR 101.9 and 101.36, a product labeled for children under 4 must use the age-appropriate RDIs in its Supplement Facts panel. A children's gummy marketed "for ages 2+" that uses adult Daily Values is technically misbranded.
Products intended for infants and children under 2 must comply with separate labeling requirements under 21 CFR 101.9(j)(5) and may not use the standard Supplement Facts format without modification.
What Claim Language Is Permissible
Under 21 CFR 101.93(f), children's supplement structure/function claims may describe support for normal growth and development. These are generally permissible:
"Supports healthy growth and development"
"Promotes healthy bone development"
"Supports healthy brain development"
"Helps maintain healthy immune function in children"
"Supports healthy vision development"
"Promotes healthy cognitive function in children"
"Supports healthy gut flora in children"
These claims describe normal pediatric development functions. They don't imply treatment of developmental disorders or pediatric disease.
Where Children's Supplement Claims Cross the Line
Prohibited disease claims in the pediatric context:
"Helps children with ADHD" — attention deficit hyperactivity disorder is a named disease; treatment or management claims require drug approval
"For kids on the autism spectrum" — autism spectrum disorder is a named developmental condition
"Supports focus in children with attention difficulties" — "attention difficulties" is a clinical descriptor for ADHD
"Reduces hyperactivity" — hyperactivity is a named symptom of ADHD under 21 CFR 101.93(g)(2)(ii)
"Improves developmental delays" — developmental delay is a clinical condition
"For children with growth deficiencies" — growth deficiency is a disease state
"Helps kids with sensory processing issues" — sensory processing disorder is a clinical condition
The "focus" and "attention" category deserves special attention
"Supports focus and attention in kids" occupies genuinely contested territory. FDA has not issued a bright-line rule on whether attention claims for children are always disease claims. But when paired with ADHD awareness imagery, recommendations from pediatric practitioners, or marketing targeting parents of children with attention difficulties, the contextual disease claim analysis under 21 CFR 101.93(g) pushes these claims toward prohibited territory.
Advertising to Children and FTC Concerns
The FTC has separate guidance on advertising directed at children under the Children's Online Privacy Protection Act (COPPA) and under its general unfair advertising authority. Marketing children's supplements with exaggerated outcome claims — "makes your child smarter," "gives your kid a supercharged immune system" — faces FTC substantiation requirements. The FTC applies the same competent and reliable scientific evidence standard, and marketing to parents (or children) without substantiation exposes brands to FTC action independent of FDA claim violations.
Serving Size for Pediatric Products
Serving sizes on children's supplements must reflect recommended pediatric dosing — not adult dosing. A product labeled for children ages 4-12 that uses a serving size based on adult dose-finding studies, without age-appropriate dose guidance, creates both safety and labeling accuracy concerns.
Children's supplements require both technical precision and conservative claim framing
The combination of age-specific Daily Values, pediatric serving sizes, and heightened disease claim sensitivity around developmental conditions makes children's supplements technically demanding on multiple fronts. Truli scans children's supplement labels for age-appropriate Daily Value usage, pediatric serving size accuracy, and developmental/behavioral claims that cross into ADHD, autism, or growth disorder territory.
A note from Truli: Truli is not a law firm, and this article does not constitute or contain legal advice or create an attorney-client relationship. When determining your obligations and compliance with respect to relevant laws and regulations, you should consult a licensed attorney.
